Homecare Diagnostics and Therapeutics Market Size, Share, and Trends 2024 to 2034

The global homecare diagnostics & therapeutics market size is calculated at USD 249.93 billion in 2024, grew to USD 269.92 billion in 2025, and is predicted to hit around USD 539.57 billion by 2034, expanding at a CAGR of 8% between 2024 and 2034.

  • Last Updated : 07 Oct 2024
  • Report Code : 1476
  • Category : Healthcare

Homecare Diagnostics and Therapeutics Market Size and Forecast 2024 to 2034

The global homecare diagnostics & therapeutics market size is expected to be valued at USD 249.93 billion in 2024 and is anticipated to reach around USD 539.57 billion by 2034, expanding at a CAGR of 8% over the forecast period from 2024 to 2034.

Homecare Diagnostics and Therapeutics Market Size 2024 to 2034

Homecare Diagnostics and Therapeutics Market Key Takeaways

  • By region, North America dominated the market in 2023.
  • By region, Asia Pacific is expected to witness rapid growth throughout the forecast period.
  • By product, the diagnostics segment dominated the market in 2023.
  • By service, the skilled nursing services segment led the market in 2023.
  • By indication, the cardiovascular disorders segment held a large share of the market in 2023.

Market Overview 

The homecare diagnostics and therapeutics market deals with a wide range of healthcare products, such as nebulizers and blood glucose level indicators, which offer individuals adequate physical support, diagnosis, and healthcare monitoring. These user-friendly and portable devices allow patients to receive treatment from the comfort of their own homes and prevent costly hospital spending. The market has witnessed significant growth in the past few years. The demand for medical devices has increased exponentially during the COVID-19 pandemic due to the rising awareness about health & wellness. Moreover, the market is expected to grow in the coming years owing to the increasing usage of mHealth techniques, such as smartphone apps and wearables, the rising adoption of user-friendly and portable diagnostics & therapeutics devices, and the growing usage of telemedicine services.

Homecare Diagnostics and Therapeutics Market Growth Factors

The global homecare diagnostics and therapeutics market is primarily driven by several factors, such as the growing geriatric population, the rising prevalence of various chronic diseases, the increasing demand for convenient and quality healthcare services, and the rising technological advancements in home care tools. Some chronic diseases often require continuous monitoring of health status to prevent life-threatening events. However, telehealth plays a crucial role in homecare diagnostics & therapeutics, as it allows patients to access healthcare services remotely and manage their conditions remotely, thus reducing frequent and unnecessary hospital visits. The proliferation of digital technologies, the rising adoption of smartphones, and improving access to the internet are the major factors that boosted the adoption of telehealth applications across the globe. Moreover, favorable government frameworks for encouraging the adoption of telehealth to reduce the pressure on hospitals have significantly driven the adoption of telehealth.

Furthermore, the rising awareness regarding hospital-acquired infections among the population is compelling consumers to opt for homecare health services. According to the World Health Organization, around 7% of hospitalized patients in developed countries and 10% in developing countries are expected to acquire at least one healthcare-associated infection. Urinary tract infections are the most frequent hospital-acquired infection in developed countries. Moreover, the growing geriatric population is a major factor propelling the homecare diagnostics and therapeutics market. 

  • According to the World Health Organization, the number of people aged 60 or above is expected to reach about 2.1 billion by 2050. 

Market Scope

Report Coverage Details
Market Size in 2024 USD 249.93 Billion
Market Size by 2034 USD 539.57 Billion
Growth Rate from 2024 to 2034 CAGR of 8%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2023
Forecast Period 2024 to 2034
Segments Covered Product, Service, Indication, and Region
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Market Dynamics 

Driver  

Reduction of hospital readmissions and enhanced safety 

For patients with chronic diseases, hospital readmissions are a common concern. In certain health conditions, people face difficulties in moving out; hence, homecare diagnostics and therapeutics play a crucial role in treating such patients. Home care services offer immediate intervention and allow patients to monitor their health from the comfort of their own homes, which can avoid complications that may cause readmission. This approach further reduces frequent hospital and emergency room visits and minimizes additional healthcare costs. In addition, homecare provides a safer alternative to institutional care. Moreover, the increasing demand for cost-effective healthcare services, the trend of self-care, and the rising adoption of medical devices drive the market during the forecast period.

Restraint

High cost and lack of reimbursement policies

The high cost associated with homecare services restrains the market. The low affordability of people in developing and underdeveloped countries may deter them from adopting homecare diagnostics & therapeutics services, creating significant market challenges. Furthermore, the lack of reimbursement policies for homecare services makes them expensive, thus creating barriers for low-income people to adopt them. 

Opportunity 

Advancements in home care tools

The rising technological advancements in home care tools create lucrative opportunities in the market. Advanced technologies, such as data analytics, wireless connectivity, and artificial intelligence, are significantly boosting the adoption of several homecare diagnostic and therapeutic devices around the world. Healthcare providers are also adopting these technologies to reduce healthcare costs. For instance, 

  • In June 2024, an Oklahoma City-based startup, Apricot, leveraged generative AI to minimize healthcare documentation, allowing home-health nurses to concentrate more on patient care.

Product Insights

The diagnostics segment dominated the global market in 2023. This is attributed to the increased prevalence of various chronic diseases such as cancer, diabetes, respiratory disorders, and arthritis. The need for continuous monitoring of health conditions has fueled the growth of the diagnostics segment. The continuous research and development activities adopted by top market players have resulted in the development of technologically advanced homecare diagnostic products, contributing to segmental growth.

The mobility care products segment is anticipated to expand at the fastest growth rate during the forecast period. The rising number of bone fractures and road traffic accidents is fueling the growth of mobility care products like wheelchairs. Certain health conditions require patients to have assistance moving from one place to another.

Service Insights 

The skilled nursing services segment dominated the global market in 2023. This is attributed to the rising adoption of skilled nursing services at home owing to the increasing geriatric population. Skilled nursing services provide more comforting solutions to patients than in a hospital or a nursing home. These services further improve patient outcomes, satisfaction, and access while reducing the total cost of care. For instance, 

  • In October 2022, Flare Capital Partners and Allina Health announced the launch of Inbound Health, a new company that enables health plans and health systems to offer skilled nursing-at-home and hospital-at-home programs. 

The rehabilitation services segment is expected to be the fastest-growing segment during the forecast period. This is attributed to the rising popularity of telerehabilitation across the globe. Moreover, the growing adoption of wearable rehabilitation products like wearable robotic exoskeletons, coupled with the rising adoption of technologies like virtual reality in physiotherapies, is expected to drive the segment growth in the forthcoming years. 

Indication Insights 

The cardiovascular disorders segment led the market with the largest share in 2023. A significant increase in unhealthy food habits, changing lifestyles, obesity, and physical inactivity leads to the increased prevalence of cardiovascular disorders. According to the World Health Organization (WHO), cardiovascular disorders are the leading cause of death around the globe, accounting for around 32% of global death. Thus, cardiovascular patients require regular monitoring and therapeutics, which fueled the growth of this segment. 

The diabetes segment is estimated to be the most opportunistic segment during the forecast period, owing to the increasing instances of diabetes. According to the data revealed by the International Diabetes Federation, around 552 million people across the globe are estimated to have diabetes by the year 2030. According to the World Health Organization, diabetes is a major cause of blindness, stroke, and kidney failure. Therefore, diabetes patients often require diagnostics and therapeutic devices to manage their conditions.

Regional Insights

North America dominated the global homecare diagnostics & therapeutics market in 2023. The increased disposable income, high healthcare expenditure, increasing awareness regarding the hospital acquired infections, and presence of huge geriatric population are the major forces that shaped the North America homecare diagnostics & therapeutics market. Moreover, around half of the US population is suffering from at least one chronic diseases, which has significantly impacted the growth of the market in the region. Moreover, the higher adoption rate of the digital technologies like telehealth is significantly contributing towards the growth of the homecare diagnostics and therapeutics market.

Asia Pacific is estimated to be the fastest-growing market during the forecast period. Asia Pacific is characterized by rising urban population, rising penetration of healthcare facilities, growing adoption of the digital technologies in the healthcare sector, growing geriatric population, rising personal disposable income, and rising healthcare expenditure, which favors the growth of the homecare diagnostics & therapeutics market in the region. According to the United Nations, around 80% of the global geriatric population will be living in the low and middle income countries. Moreover, the rising road traffic accidents is fueling the demand for the homecare services. According to the World Health Organization, around 93% of the road traffic accidents occur in the low and middle income countries.

Homecare Diagnostics & Therapeutics Market Companies

  • Fresenius SE & Co. KGaA
  • GE Healthcare
  • Linde plc
  • F. Hoffmann-La Roche Ltd.
  • A&D Company
  • BAYADA Home Health Care
  • Invacare Corporation
  • Abbott
  • Amedisys
  • ResMed

Recent Developments

  •  In September 2023, Apollo Hospitals launched India’s first Comprehensive Connected Care program powered by Apollo’s Connected Care technology. This service offers nursing staff and clinical teams across various care touchpoints and patient journeys, such as home care, post-surgery, Inpatient, emergency, and ambulance.  
  • In July 2023, Allied Insurance Company and Star Health launched home healthcare services in 50 towns and cities in India. The aim behind this launch was to provide healthcare service at the doorstep of the customers.  

Segments Covered in the Report

By Product

  • Diagnostics
  • Therapeutics
  • Mobility Care Products

By Service

  • Rehabilitation Therapy Services
  • Skilled Nursing Services
  • Respiratory Therapy Services
  • Pregnancy Care Services
  • Infusion Therapy Services
  • Others

By Indication

  • Cardiovascular Disorders
  • Cancer
  • Diabetes
  • Respiratory Diseases
  • Wound Care
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • MEA
  • Latin America
  • Rest of the World

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global homecare diagnostics & therapeutics market size was estimated at USD 249.93 billion in 2024 and is predicted to surpass USD 539.57 billion by 2034.

The global homecare diagnostics & therapeutics market is expanding growth at a CAGR of 8% from 2024 to 2034.

The rising adoption of telehealth across the globe coupled with the favorable regulatory framework of the government to encourage the adoption of the telehealth are the major factors that are expected to drive the growth of the global homecare diagnostics & therapeutics market.

The major players operating in the homecare diagnostics & therapeutics market are Fresenius SE & Co. KGaA, GE Healthcare, Linde plc, F. Hoffmann-La Roche Ltd., A&D Company, BAYADA Home Health Care, Invacare Corporation, Abbott, Amedisys, ResMed.

North America was the dominant homecare diagnostics & therapeutics market in 2024. This is simply attributable to the increased prevalence of chronic diseases. Over half of the US population is suffering from one or more chronic diseases.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Meet the Team

Deepa Pandey, one of our esteemed authors, plays a crucial role in shaping the high-quality content that defines our research reports. Deepa holds a Master's in Pharmacy with a specialization in Pharmaceutical Quality Assurance, equipping her with an in-depth understanding of the healthcare industry's regulatory, quality, and operational nuances. With 2+ years of experience in market research, Deepa has made

Learn more about Deepa Pandey

With over 14 years of experience, Aditi is the powerhouse responsible for reviewing every piece of data and content that passes through our research pipeline. She is not just an expert—she’s the linchpin that ensures the accuracy, relevance, and clarity of the insights we deliver. Aditi’s broad expertise spans multiple sectors, with a keen focus on ICT, automotive, and various other cross-domain industries.

Learn more about Aditi Shivarkar

Related Reports